3-aminocyclohexan-1-ol;bis(4-chloro-3-isocyanopyrrolo[1,2-b]pyridazine);4-[(3-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;4-[(4-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;3-isocyano-N-(oxolan-2-ylmethyl)pyrrolo[1,2-b]pyridazin-4-amine;3-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;4-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;oxolan-2-ylmethanamine;4-(oxolan-2-ylmethylamino)pyrrolo[1,2-b]pyridazine-3-carboxamide
C109H130Cl2N32O11 — CID 159968851
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-aminocyclohexan-1-ol;bis(4-chloro-3-isocyanopyrrolo[1,2-b]pyridazine);4-[(3-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;4-[(4-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;3-isocyano-N-(oxolan-2-ylmethyl)pyrrolo[1,2-b]pyridazin-4-amine;3-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;4-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;oxolan-2-ylmethanamine;4-(oxolan-2-ylmethylamino)pyrrolo[1,2-b]pyridazine-3-carboxamide
3-aminocyclohexan-1-ol;bis(4-chloro-3-isocyanopyrrolo[1,2-b]pyridazine);4-[(3-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;4-[(4-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;3-isocyano-N-(oxolan-2-ylmethyl)pyrrolo[1,2-b]pyridazin-4-amine;3-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;4-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;oxolan-2-ylmethanamine;4-(oxolan-2-ylmethylamino)pyrrolo[1,2-b]pyridazine-3-carboxamide (PubChem CID 159968851) has the molecular formula C109H130Cl2N32O11 and a molecular weight of 2135.36 g/mol. Its IUPAC name is 3-aminocyclohexan-1-ol;bis(4-chloro-3-isocyanopyrrolo[1,2-b]pyridazine);4-[(3-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;4-[(4-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;3-isocyano-N-(oxolan-2-ylmethyl)pyrrolo[1,2-b]pyridazin-4-amine;3-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;4-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;oxolan-2-ylmethanamine;4-(oxolan-2-ylmethylamino)pyrrolo[1,2-b]pyridazine-3-carboxamide.
Molecular Properties
| Compound Name | 3-aminocyclohexan-1-ol;bis(4-chloro-3-isocyanopyrrolo[1,2-b]pyridazine);4-[(3-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;4-[(4-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;3-isocyano-N-(oxolan-2-ylmethyl)pyrrolo[1,2-b]pyridazin-4-amine;3-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;4-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;oxolan-2-ylmethanamine;4-(oxolan-2-ylmethylamino)pyrrolo[1,2-b]pyridazine-3-carboxamide |
|---|---|
| PubChem CID | 159968851 |
| Molecular Formula | C109H130Cl2N32O11 |
| Molecular Weight | 2135.36 g/mol |
| Exact Mass | 2133.00 |
| IUPAC Name | 3-aminocyclohexan-1-ol;bis(4-chloro-3-isocyanopyrrolo[1,2-b]pyridazine);4-[(3-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;4-[(4-hydroxycyclohexyl)amino]pyrrolo[1,2-b]pyridazine-3-carboxamide;3-isocyano-N-(oxolan-2-ylmethyl)pyrrolo[1,2-b]pyridazin-4-amine;3-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;4-[(3-isocyanopyrrolo[1,2-b]pyridazin-4-yl)amino]cyclohexan-1-ol;oxolan-2-ylmethanamine;4-(oxolan-2-ylmethylamino)pyrrolo[1,2-b]pyridazine-3-carboxamide |
| SMILES | NC(=O)c1cnn2cccc2c1NC1CCC(O)CC1.NC(=O)c1cnn2cccc2c1NC1CCCC(O)C1.NC(=O)c1cnn2cccc2c1NCC1CCCO1.NC1CCCC(O)C1.NCC1CCCO1.[C-]#[N+]c1cnn2cccc2c1Cl.[C-]#[N+]c1cnn2cccc2c1Cl.[C-]#[N+]c1cnn2cccc2c1NC1CCC(O)CC1.[C-]#[N+]c1cnn2cccc2c1NC1CCCC(O)C1.[C-]#[N+]c1cnn2cccc2c1NCC1CCCO1 |
| InChI | InChI=1S/2C14H18N4O2.2C14H16N4O.C13H16N4O2.C13H14N4O.2C8H4ClN3.C6H13NO.C5H11NO/c15-14(20)11-8-16-18-6-2-5-12(18)13(11)17-9-3-1-4-10(19)7-9;15-14(20)11-8-16-18-7-1-2-12(18)13(11)17-9-3-5-10(19)6-4-9;1-15-12-9-16-18-7-3-6-13(18)14(12)17-10-4-2-5-11(19)8-10;1-15-12-9-16-18-8-2-3-13(18)14(12)17-10-4-6-11(19)7-5-10;14-13(18)10-8-16-17-5-1-4-11(17)12(10)15-7-9-3-2-6-19-9;1-14-11-9-16-17-6-2-5-12(17)13(11)15-8-10-4-3-7-18-10;2*1-10-6-5-11-12-4-2-3-7(12)8(6)9;7-5-2-1-3-6(8)4-5;6-4-5-2-1-3-7-5/h2,5-6,8-10,17,19H,1,3-4,7H2,(H2,15,20);1-2,7-10,17,19H,3-6H2,(H2,15,20);3,6-7,9-11,17,19H,2,4-5,8H2;2-3,8-11,17,19H,4-7H2;1,4-5,8-9,15H,2-3,6-7H2,(H2,14,18);2,5-6,9-10,15H,3-4,7-8H2;2*2-5H;5-6,8H,1-4,7H2;5H,1-4,6H2 |
| InChIKey | OEGVQZHZCSMCSG-UHFFFAOYSA-N |
| XLogP | 16.45 |
| TPSA | 542.53 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 154 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2135.36 |
| LogP ≤ 5 | 16.45 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 35 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159968851 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.